These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Major congenital malformations after first-trimester exposure to ACE inhibitors. Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444 [TBL] [Abstract][Full Text] [Related]
3. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. Li DK; Yang C; Andrade S; Tavares V; Ferber JR BMJ; 2011 Oct; 343():d5931. PubMed ID: 22010128 [TBL] [Abstract][Full Text] [Related]
4. β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study. Bateman BT; Heide-Jørgensen U; Einarsdóttir K; Engeland A; Furu K; Gissler M; Hernandez-Diaz S; Kieler H; Lahesmaa-Korpinen AM; Mogun H; Nørgaard M; Reutfors J; Selmer R; Huybrechts KF; Zoega H Ann Intern Med; 2018 Nov; 169(10):665-673. PubMed ID: 30326014 [TBL] [Abstract][Full Text] [Related]
5. In utero exposure to antibiotics and risk of congenital malformations: a population-based study. Damkier P; Brønniche LMS; Korch-Frandsen JFB; Broe A Am J Obstet Gynecol; 2019 Dec; 221(6):648.e1-648.e15. PubMed ID: 31260651 [TBL] [Abstract][Full Text] [Related]
6. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479 [TBL] [Abstract][Full Text] [Related]
7. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors. Cooper WO J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502 [TBL] [Abstract][Full Text] [Related]
9. Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis. Fu J; Tomlinson G; Feig DS Diabetes Metab Res Rev; 2021 Nov; 37(8):e3453. PubMed ID: 33779043 [TBL] [Abstract][Full Text] [Related]
10. Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium. Huybrechts KF; Bröms G; Christensen LB; Einarsdóttir K; Engeland A; Furu K; Gissler M; Hernandez-Diaz S; Karlsson P; Karlstad Ø; Kieler H; Lahesmaa-Korpinen AM; Mogun H; Nørgaard M; Reutfors J; Sørensen HT; Zoega H; Bateman BT JAMA Psychiatry; 2018 Feb; 75(2):167-175. PubMed ID: 29238795 [TBL] [Abstract][Full Text] [Related]
12. First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations. Suarez EA; Bateman BT; Straub L; Hernández-Díaz S; Jones HE; Gray KJ; Connery HS; Davis JM; Lester B; Terplan M; Zhu Y; Vine SM; Mogun H; Huybrechts KF JAMA Intern Med; 2024 Mar; 184(3):242-251. PubMed ID: 38252426 [TBL] [Abstract][Full Text] [Related]
13. Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Bateman BT; Huybrechts KF; Fischer MA; Seely EW; Ecker JL; Oberg AS; Franklin JM; Mogun H; Hernandez-Diaz S Am J Obstet Gynecol; 2015 Mar; 212(3):337.e1-14. PubMed ID: 25265405 [TBL] [Abstract][Full Text] [Related]
14. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. Zhu Y; Bateman BT; Gray KJ; Hernandez-Diaz S; Mogun H; Straub L; Huybrechts KF BMJ; 2020 May; 369():m1494. PubMed ID: 32434758 [TBL] [Abstract][Full Text] [Related]
15. Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital Malformations. Choi A; Noh Y; Jeong HE; Choi EY; Man KKC; Han JY; Kim HS; Yon DK; Shin JY JAMA Netw Open; 2023 Jan; 6(1):e2250366. PubMed ID: 36626173 [TBL] [Abstract][Full Text] [Related]
16. Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset. Patorno E; Hernandez-Diaz S; Huybrechts KF; Desai RJ; Cohen JM; Mogun H; Bateman BT PLoS Med; 2020 Sep; 17(9):e1003322. PubMed ID: 32870921 [TBL] [Abstract][Full Text] [Related]
17. Pregabalin use early in pregnancy and the risk of major congenital malformations. Patorno E; Bateman BT; Huybrechts KF; MacDonald SC; Cohen JM; Desai RJ; Panchaud A; Mogun H; Pennell PB; Hernandez-Diaz S Neurology; 2017 May; 88(21):2020-2025. PubMed ID: 28446648 [TBL] [Abstract][Full Text] [Related]
18. Bupropion in pregnancy and the prevalence of congenital malformations. Cole JA; Modell JG; Haight BR; Cosmatos IS; Stoler JM; Walker AM Pharmacoepidemiol Drug Saf; 2007 May; 16(5):474-84. PubMed ID: 16897811 [TBL] [Abstract][Full Text] [Related]
19. Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. Huybrechts KF; Straub L; Karlsson P; Pazzagli L; Furu K; Gissler M; Hernandez-Diaz S; Nørgaard M; Zoega H; Bateman BT; Cesta CE; Cohen JM; Leinonen MK; Reutfors J; Selmer RM; Suarez EA; Ulrichsen SP; Kieler H JAMA Psychiatry; 2023 Feb; 80(2):156-166. PubMed ID: 36477338 [TBL] [Abstract][Full Text] [Related]
20. Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations. Wen X; Belviso N; Murray E; Lewkowitz AK; Ward KE; Meador KJ JAMA Netw Open; 2021 Apr; 4(4):e215708. PubMed ID: 33847750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]